Home ➤ Life Science ➤ Biotechnology ➤ Genome Editing Market
Genome Editing Market
Published date: Jan 2025 • Formats:
Request Sample Schedule a Call

Genome Editing Market By Delivery Method (Ex-vivo and In-vivo), By Technology (CRISPR/Cas9, Meganuclease, TALENs/MegaTALs, ZFN, and Others), By Application (Genetic Engineering (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering, and Others) and Clinical Applications (Diagnostics and Therapy Development)), By End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Jan 2025
  • Report ID: 138474
  • Number of Pages: 221
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Genome Editing Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Genome Editing Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Genome Editing Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Delivery Method, 2020-2034
      • 3.3. Global Genome Editing Market Attractiveness Analysis, By Delivery Method
        • 3.3.1. Ex-vivo
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. In-vivo
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
      • 3.4. Global Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 3.5. Global Genome Editing Market Attractiveness Analysis, By Technology
        • 3.5.1. CRISPR/Cas9
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Meganuclease
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. TALENs/MegaTALs
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. ZFN
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Others
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
      • 3.6. Global Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.7. Global Genome Editing Market Attractiveness Analysis, By Application
        • 3.7.1. Genetic Engineering
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
            • 3.7.1.2.1. Animal Genetic Engineering
            • 3.7.1.2.2. Cell Line Engineering
            • 3.7.1.2.3. Plant Genetic Engineering
            • 3.7.1.2.4. Others
        • 3.7.2. Clinical Applications
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
            • 3.7.2.2.1. Diagnostics
            • 3.7.2.2.2. Therapy Development
      • 3.8. Global Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2020-2034
      • 3.9. Global Genome Editing Market Attractiveness Analysis, By End-use
        • 3.9.1. Biotechnology & Pharmaceutical Companies
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Academic & Government Research Institutes
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Contract Research Organizations
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
    • 4. Global Genome Editing Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Genome Editing Market Attractiveness Analysis, By Region
    • 5. North America Genome Editing Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Delivery Method, 2020-2034
      • 5.3. North America Genome Editing Market Attractiveness Analysis, By Delivery Method
      • 5.4. North America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 5.5. North America Genome Editing Market Attractiveness Analysis, By Technology
      • 5.6. North America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.7. North America Genome Editing Market Attractiveness Analysis, By Application
      • 5.8. North America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2020-2034
      • 5.9. North America Genome Editing Market Attractiveness Analysis, By End-use
      • 5.10. North America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.11. North America Genome Editing Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Genome Editing Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Delivery Method, 2020-2034
      • 6.3. Europe Genome Editing Market Attractiveness Analysis, By Delivery Method
      • 6.4. Europe Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 6.5. Europe Genome Editing Market Attractiveness Analysis, By Technology
      • 6.6. Europe Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.7. Europe Genome Editing Market Attractiveness Analysis, By Application
      • 6.8. Europe Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2020-2034
      • 6.9. Europe Genome Editing Market Attractiveness Analysis, By End-use
      • 6.10. Europe Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.11. Europe Genome Editing Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherland
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Genome Editing Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Delivery Method, 2020-2034
      • 7.3. Asia Pacific Genome Editing Market Attractiveness Analysis, By Delivery Method
      • 7.4. Asia Pacific Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 7.5. Asia Pacific Genome Editing Market Attractiveness Analysis, By Technology
      • 7.6. Asia Pacific Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.7. Asia Pacific Genome Editing Market Attractiveness Analysis, By Application
      • 7.8. Asia Pacific Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2020-2034
      • 7.9. Asia Pacific Genome Editing Market Attractiveness Analysis, By End-use
      • 7.10. Asia Pacific Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.11. Asia Pacific Genome Editing Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. Australia
        • 7.11.6. New Zealand
        • 7.11.7. Singapore
        • 7.11.8. Thailand
        • 7.11.9. Vietnam
        • 7.11.10. Rest of Asia Pacific
    • 8. Latin America Genome Editing Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Delivery Method, 2020-2034
      • 8.3. Latin America Genome Editing Market Attractiveness Analysis, By Delivery Method
      • 8.4. Latin America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 8.5. Latin America Genome Editing Market Attractiveness Analysis, By Technology
      • 8.6. Latin America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.7. Latin America Genome Editing Market Attractiveness Analysis, By Application
      • 8.8. Latin America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2020-2034
      • 8.9. Latin America Genome Editing Market Attractiveness Analysis, By End-use
      • 8.10. Latin America Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.11. Latin America Genome Editing Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Genome Editing Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Delivery Method, 2020-2034
      • 9.3. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Delivery Method
      • 9.4. Middle East & Africa Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 9.5. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Technology
      • 9.6. Middle East & Africa Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.7. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Application
      • 9.8. Middle East & Africa Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2020-2034
      • 9.9. Middle East & Africa Genome Editing Market Attractiveness Analysis, By End-use
      • 9.10. Middle East & Africa Genome Editing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.11. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Sangamo Therapeutics
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Recombinetics
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Precision BioSciences
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. LGC
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Editas Medicine
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. CRISPR Therapeutics
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Cellectis
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. AstraZeneca
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 2. Global Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 3. Global Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 4. Global Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 5. Global Genome Editing Market Value (US$ Mn), By Region, 2020-2034
      • Table 6. North America Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 7. North America Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 8. North America Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 9. North America Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 10. North America Genome Editing Market Value (US$ Mn), By Country, 2020-2034
      • Table 11. The US Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 12. The US Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 13. The US Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 14. The US Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 15. Canada Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 16. Canada Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 17. Canada Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 18. Canada Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 19. Europe Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 20. Europe Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 21. Europe Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 22. Europe Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 23. Europe Genome Editing Market Value (US$ Mn), By Country, 2020-2034
      • Table 24. Germany Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 25. Germany Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 26. Germany Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 27. Germany Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 28. The UK Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 29. The UK Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 30. The UK Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 31. The UK Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 32. France Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 33. France Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 34. France Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 35. France Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 36. Spain Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 37. Spain Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 38. Spain Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 39. Spain Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 40. Italy Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 41. Italy Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 42. Italy Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 43. Italy Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 44. Russia Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 45. Russia Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 46. Russia Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 47. Russia Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 48. Netherland Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 49. Netherland Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 50. Netherland Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 51. Netherland Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 52. Rest of Europe Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 53. Rest of Europe Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 54. Rest of Europe Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 55. Rest of Europe Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 56. Asia Pacific Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 57. Asia Pacific Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 58. Asia Pacific Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 59. Asia Pacific Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 60. Asia Pacific Genome Editing Market Value (US$ Mn), By Country, 2020-2034
      • Table 61. China Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 62. China Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 63. China Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 64. China Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 65. India Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 66. India Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 67. India Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 68. India Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 69. Japan Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 70. Japan Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 71. Japan Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 72. Japan Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 73. South Korea Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 74. South Korea Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 75. South Korea Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 76. South Korea Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 77. Australia Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 78. Australia Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 79. Australia Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 80. Australia Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 81. New Zealand Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 82. New Zealand Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 83. New Zealand Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 84. New Zealand Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 85. Singapore Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 86. Singapore Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 87. Singapore Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 88. Singapore Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 89. Thailand Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 90. Thailand Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 91. Thailand Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 92. Thailand Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 93. Vietnam Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 94. Vietnam Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 95. Vietnam Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 96. Vietnam Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 97. Rest of Asia Pacific Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 98. Rest of Asia Pacific Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 99. Rest of Asia Pacific Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 100. Rest of Asia Pacific Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 101. Latin America Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 102. Latin America Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 103. Latin America Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 104. Latin America Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 105. Latin America Genome Editing Market Value (US$ Mn), By Country, 2020-2034
      • Table 106. Brazil Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 107. Brazil Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 108. Brazil Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 109. Brazil Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 110. Mexico Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 111. Mexico Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 112. Mexico Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 113. Mexico Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 114. Rest of Latin America Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 115. Rest of Latin America Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 116. Rest of Latin America Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 117. Rest of Latin America Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 118. Middle East & Africa Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 119. Middle East & Africa Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 120. Middle East & Africa Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 121. Middle East & Africa Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 122. Middle East & Africa Genome Editing Market Value (US$ Mn), By Country, 2020-2034
      • Table 123. South Africa Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 124. South Africa Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 125. South Africa Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 126. South Africa Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 127. Saudi Arabia Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 128. Saudi Arabia Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 129. Saudi Arabia Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 130. Saudi Arabia Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 131. UAE Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 132. UAE Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 133. UAE Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 134. UAE Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
      • Table 135. Rest of Middle East & Africa Genome Editing Market Value (US$ Mn), By Delivery Method, 2020-2034
      • Table 136. Rest of Middle East & Africa Genome Editing Market Value (US$ Mn), By Technology, 2020-2034
      • Table 137. Rest of Middle East & Africa Genome Editing Market Value (US$ Mn), By Application, 2020-2034
      • Table 138. Rest of Middle East & Africa Genome Editing Market Value (US$ Mn), By End-use, 2020-2034
    • List of Figures
      • Figure 1. Global Genome Editing Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Genome Editing Market
      • Figure 5. Global Genome Editing Market Analysis, By Delivery Method, 2020, 2024 and 2034
      • Figure 6. Global Genome Editing Market Attractiveness Analysis, By Delivery Method
      • Figure 7. Global Genome Editing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 8. Global Genome Editing Market Attractiveness Analysis, By Technology
      • Figure 9. Global Genome Editing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 10. Global Genome Editing Market Attractiveness Analysis, By Application
      • Figure 11. Global Genome Editing Market Analysis, By End-use, 2020, 2024 and 2034
      • Figure 12. Global Genome Editing Market Attractiveness Analysis, By End-use
      • Figure 13. Global Genome Editing Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 14. Global Genome Editing Market Attractiveness Analysis, By Region
      • Figure 15. North America Genome Editing Market Analysis, By Delivery Method, 2020, 2024 and 2034
      • Figure 16. North America Genome Editing Market Attractiveness Analysis, By Delivery Method
      • Figure 17. North America Genome Editing Market (US$ Mn), by Ex-vivo, 2020-2034
      • Figure 18. North America Genome Editing Market (US$ Mn), by In-vivo, 2020-2034
      • Figure 19. North America Genome Editing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 20. North America Genome Editing Market Attractiveness Analysis, By Technology
      • Figure 21. North America Genome Editing Market (US$ Mn), by CRISPR/Cas9, 2020-2034
      • Figure 22. North America Genome Editing Market (US$ Mn), by Meganuclease, 2020-2034
      • Figure 23. North America Genome Editing Market (US$ Mn), by TALENs/MegaTALs, 2020-2034
      • Figure 24. North America Genome Editing Market (US$ Mn), by ZFN, 2020-2034
      • Figure 25. North America Genome Editing Market (US$ Mn), by Others, 2020-2034
      • Figure 26. North America Genome Editing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 27. North America Genome Editing Market Attractiveness Analysis, By Application
      • Figure 28. North America Genome Editing Market (US$ Mn), by Genetic Engineering, 2020-2034
      • Figure 29. North America Genome Editing Market (US$ Mn), by Clinical Applications, 2020-2034
      • Figure 30. North America Genome Editing Market Analysis, By End-use, 2020, 2024 and 2034
      • Figure 31. North America Genome Editing Market Attractiveness Analysis, By End-use
      • Figure 32. North America Genome Editing Market (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2020-2034
      • Figure 33. North America Genome Editing Market (US$ Mn), by Academic & Government Research Institutes, 2020-2034
      • Figure 34. North America Genome Editing Market (US$ Mn), by Contract Research Organizations, 2020-2034
      • Figure 35. North America Genome Editing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 36. North America Genome Editing Market Attractiveness Analysis, By Country
      • Figure 37. Europe Genome Editing Market Analysis, By Delivery Method, 2020, 2024 and 2034
      • Figure 38. Europe Genome Editing Market Attractiveness Analysis, By Delivery Method
      • Figure 39. Europe Genome Editing Market (US$ Mn), by Ex-vivo, 2020-2034
      • Figure 40. Europe Genome Editing Market (US$ Mn), by In-vivo, 2020-2034
      • Figure 41. Europe Genome Editing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 42. Europe Genome Editing Market Attractiveness Analysis, By Technology
      • Figure 43. Europe Genome Editing Market (US$ Mn), by CRISPR/Cas9, 2020-2034
      • Figure 44. Europe Genome Editing Market (US$ Mn), by Meganuclease, 2020-2034
      • Figure 45. Europe Genome Editing Market (US$ Mn), by TALENs/MegaTALs, 2020-2034
      • Figure 46. Europe Genome Editing Market (US$ Mn), by ZFN, 2020-2034
      • Figure 47. Europe Genome Editing Market (US$ Mn), by Others, 2020-2034
      • Figure 48. Europe Genome Editing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 49. Europe Genome Editing Market Attractiveness Analysis, By Application
      • Figure 50. Europe Genome Editing Market (US$ Mn), by Genetic Engineering, 2020-2034
      • Figure 51. Europe Genome Editing Market (US$ Mn), by Clinical Applications, 2020-2034
      • Figure 52. Europe Genome Editing Market Analysis, By End-use, 2020, 2024 and 2034
      • Figure 53. Europe Genome Editing Market Attractiveness Analysis, By End-use
      • Figure 54. Europe Genome Editing Market (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2020-2034
      • Figure 55. Europe Genome Editing Market (US$ Mn), by Academic & Government Research Institutes, 2020-2034
      • Figure 56. Europe Genome Editing Market (US$ Mn), by Contract Research Organizations, 2020-2034
      • Figure 57. Europe Genome Editing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 58. Europe Genome Editing Market Attractiveness Analysis, By Country
      • Figure 59. Asia Pacific Genome Editing Market Analysis, By Delivery Method, 2020, 2024 and 2034
      • Figure 60. Asia Pacific Genome Editing Market Attractiveness Analysis, By Delivery Method
      • Figure 61. Asia Pacific Genome Editing Market (US$ Mn), by Ex-vivo, 2020-2034
      • Figure 62. Asia Pacific Genome Editing Market (US$ Mn), by In-vivo, 2020-2034
      • Figure 63. Asia Pacific Genome Editing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 64. Asia Pacific Genome Editing Market Attractiveness Analysis, By Technology
      • Figure 65. Asia Pacific Genome Editing Market (US$ Mn), by CRISPR/Cas9, 2020-2034
      • Figure 66. Asia Pacific Genome Editing Market (US$ Mn), by Meganuclease, 2020-2034
      • Figure 67. Asia Pacific Genome Editing Market (US$ Mn), by TALENs/MegaTALs, 2020-2034
      • Figure 68. Asia Pacific Genome Editing Market (US$ Mn), by ZFN, 2020-2034
      • Figure 69. Asia Pacific Genome Editing Market (US$ Mn), by Others, 2020-2034
      • Figure 70. Asia Pacific Genome Editing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 71. Asia Pacific Genome Editing Market Attractiveness Analysis, By Application
      • Figure 72. Asia Pacific Genome Editing Market (US$ Mn), by Genetic Engineering, 2020-2034
      • Figure 73. Asia Pacific Genome Editing Market (US$ Mn), by Clinical Applications, 2020-2034
      • Figure 74. Asia Pacific Genome Editing Market Analysis, By End-use, 2020, 2024 and 2034
      • Figure 75. Asia Pacific Genome Editing Market Attractiveness Analysis, By End-use
      • Figure 76. Asia Pacific Genome Editing Market (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2020-2034
      • Figure 77. Asia Pacific Genome Editing Market (US$ Mn), by Academic & Government Research Institutes, 2020-2034
      • Figure 78. Asia Pacific Genome Editing Market (US$ Mn), by Contract Research Organizations, 2020-2034
      • Figure 79. Asia Pacific Genome Editing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 80. Asia Pacific Genome Editing Market Attractiveness Analysis, By Country
      • Figure 81. Latin America Genome Editing Market Analysis, By Delivery Method, 2020, 2024 and 2034
      • Figure 82. Latin America Genome Editing Market Attractiveness Analysis, By Delivery Method
      • Figure 83. Latin America Genome Editing Market (US$ Mn), by Ex-vivo, 2020-2034
      • Figure 84. Latin America Genome Editing Market (US$ Mn), by In-vivo, 2020-2034
      • Figure 85. Latin America Genome Editing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 86. Latin America Genome Editing Market Attractiveness Analysis, By Technology
      • Figure 87. Latin America Genome Editing Market (US$ Mn), by CRISPR/Cas9, 2020-2034
      • Figure 88. Latin America Genome Editing Market (US$ Mn), by Meganuclease, 2020-2034
      • Figure 89. Latin America Genome Editing Market (US$ Mn), by TALENs/MegaTALs, 2020-2034
      • Figure 90. Latin America Genome Editing Market (US$ Mn), by ZFN, 2020-2034
      • Figure 91. Latin America Genome Editing Market (US$ Mn), by Others, 2020-2034
      • Figure 92. Latin America Genome Editing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 93. Latin America Genome Editing Market Attractiveness Analysis, By Application
      • Figure 94. Latin America Genome Editing Market (US$ Mn), by Genetic Engineering, 2020-2034
      • Figure 95. Latin America Genome Editing Market (US$ Mn), by Clinical Applications, 2020-2034
      • Figure 96. Latin America Genome Editing Market Analysis, By End-use, 2020, 2024 and 2034
      • Figure 97. Latin America Genome Editing Market Attractiveness Analysis, By End-use
      • Figure 98. Latin America Genome Editing Market (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2020-2034
      • Figure 99. Latin America Genome Editing Market (US$ Mn), by Academic & Government Research Institutes, 2020-2034
      • Figure 100. Latin America Genome Editing Market (US$ Mn), by Contract Research Organizations, 2020-2034
      • Figure 101. Latin America Genome Editing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 102. Latin America Genome Editing Market Attractiveness Analysis, By Country
      • Figure 103. Middle East & Africa Genome Editing Market Analysis, By Delivery Method, 2020, 2024 and 2034
      • Figure 104. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Delivery Method
      • Figure 105. Middle East & Africa Genome Editing Market (US$ Mn), by Ex-vivo, 2020-2034
      • Figure 106. Middle East & Africa Genome Editing Market (US$ Mn), by In-vivo, 2020-2034
      • Figure 107. Middle East & Africa Genome Editing Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 108. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Technology
      • Figure 109. Middle East & Africa Genome Editing Market (US$ Mn), by CRISPR/Cas9, 2020-2034
      • Figure 110. Middle East & Africa Genome Editing Market (US$ Mn), by Meganuclease, 2020-2034
      • Figure 111. Middle East & Africa Genome Editing Market (US$ Mn), by TALENs/MegaTALs, 2020-2034
      • Figure 112. Middle East & Africa Genome Editing Market (US$ Mn), by ZFN, 2020-2034
      • Figure 113. Middle East & Africa Genome Editing Market (US$ Mn), by Others, 2020-2034
      • Figure 114. Middle East & Africa Genome Editing Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 115. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Application
      • Figure 116. Middle East & Africa Genome Editing Market (US$ Mn), by Genetic Engineering, 2020-2034
      • Figure 117. Middle East & Africa Genome Editing Market (US$ Mn), by Clinical Applications, 2020-2034
      • Figure 118. Middle East & Africa Genome Editing Market Analysis, By End-use, 2020, 2024 and 2034
      • Figure 119. Middle East & Africa Genome Editing Market Attractiveness Analysis, By End-use
      • Figure 120. Middle East & Africa Genome Editing Market (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2020-2034
      • Figure 121. Middle East & Africa Genome Editing Market (US$ Mn), by Academic & Government Research Institutes, 2020-2034
      • Figure 122. Middle East & Africa Genome Editing Market (US$ Mn), by Contract Research Organizations, 2020-2034
      • Figure 123. Middle East & Africa Genome Editing Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 124. Middle East & Africa Genome Editing Market Attractiveness Analysis, By Country
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Genome Editing Market
  • 138474
  • Jan 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options